Novartis OTCs Fit Well With Pharma Core - CFO
This article was originally published in The Tan Sheet
Executive Summary
Novartis' nutritional and eye care businesses are seen as "farther away" from the company's core pharmaceutical focus going forward, CFO Raymund Breu told a J.P. Morgan CEO conference on building shareholder value April 26.